The Noonday Demon

Collapsed discipline, scattered focus and stubborn depression are often treated as three failures with three fixes. Older wisdom saw one sign — and newer science arrives at the same place

Giovanni Bellini’s St Francis in the desert.

In the fourth-century Egyptian desert, the monks had a name for the thing that came for them at midday. They called it the noonday demon, after the destruction that wastes at noon in the Psalm. It struck when the sun stood highest. It made the hours seem to stop. It filled the one it afflicted with a restless disgust for the task at hand and the place they were in, and a longing to be anywhere else. Evagrius of Pontus, who catalogued it, called the condition acedia, and he did not break it into parts. He treated it as one thingⁱ.

The phrase outlived the monks. A reader today is likelier to know it as the title of Andrew Solomon’s The Noonday Demon, the great modern atlas of depression — a book that maps the illness across its full range and depth. But an atlas charts a territory taken as given; the desert monks did something different, reading the noonday demon not as a country to be surveyed but as a message to be deciphered.

The modern mind usually does neither. A person who suffers the condition today often tells themselves they have not one thing but three. The fragmentation encouraged by those who have something to sell. For the collapsed discipline there is a system — habit stacks, accountability partners, a calendar tiled edge to edge. For the scattered attention there is a regimen of subtraction — applications blocked, notifications silenced, the phone exiled to another room. For the grey weight there is a diagnosis and, often, a prescription for the chemical the brain is presumed to lack. Three malfunctions, three repairs, three industries.

None of this is a fraud. Structure genuinely externalizes a will that has weakened, and many are helped by it; a silenced phone really does return some hours to the day. The talking therapies are not theater either: behavioral activation, among the best-studied treatments for depression, reliably lifts people out of it, and the meta-analytic record assembled over two decades by Pim Cuijpers and others is not a record of nothingⁱⁱ. Nor is the medication strictly a placebo in disguise. The largest synthesis ever built — a network meta-analysis of 522 trials and 116,477 patients — found all twenty-one antidepressants studied more effective than a dummy pill in acute depression¹. To wave any of it away is to argue against the evidence instead of from it.

But the same literature, read to the last page, fully digested, does tell us something very concerning that the headlines omit. The advantage of drug over placebo is small — on the standard rating scales, a difference of roughly two points out of fifty-two — and for most patients it falls short of the three-point margin that Britain’s clinical-guidance body set as the threshold for a change a person could feel, clearing that bar only at the most severe end². The story that sold the pills — that depression is a shortage of serotonin the way scurvy is a shortage of vitamin C — turns out to have no consistent evidence behind it at all³. And when dozens of psychiatrists rose to defend the field, their rejoinder was revealing: no serious researcher, they said, had ever held so crude a modelⁱⁱⁱ — a strange thing to say about an idea that had saturated a generation of drug advertising, which told the public, in language the science never supported, that their suffering was a serotonin imbalance a pill could set right [iv]. Meanwhile, the record itself was heavily curated for both public and professional consumption: checked against the complete set of trials held by regulators, the published literature showed ninety-four percent positive where the full data showed fifty-one⁴. The trial most often cited to prove that persistence pays — that switching drug after drug eventually remits most patients — yields, on a contested reanalysis, a true cumulative remission nearer thirty-five percent than the celebrated sixty-seven⁵. This is the familiar signature of a captured field, not a sinister cabal. Upton Sinclair famously pinpointed the banal mechanism in 1935: “It is difficult to get a man to understand something, when his salary depends upon his not understanding it.”

The deeper error, though, is not in the size of the effect, nor even in the curation of the record. Those are scandals to be sure, but the deeper error is one of kind — the premise that the heaviness is a malfunction at all.

Watch what a body does when it is fighting an infection. It withdraws. Appetite falls, energy drops, interest narrows, sleep distorts, the world loses its savor. No good physician mistakes the symptoms for the disease; it is sickness behavior, an evolved program that pulls resources back from the periphery toward the fight, and it runs on the cytokines a stressed or infected body releases. Give any healthy person those cytokines and low mood follows; take the measure of the depressed and the markers are often raised^{6, 7}. This does not prove that every depression is a useful maneuver; a withdrawal held open too long becomes a burden of its own. But it is more reasonable to begin looking for a solution from within this paradigm than from the mainstream one that admits to not knowing the cause of depression or any other complex chronic disease. If depression is an adaptive retreat perhaps the first question should not be what has broken but what the retreat is from.

Depression like all diseases may also be a message. One serious evolutionary reading holds that the rumination of depression — the mind circling a problem it cannot set down — is not malfunction but function: a costly state that seizes attention and pins it to a complex situation the person has failed to resolve⁸. On this account the grey weight is the organism halting a life that is going wrong and refusing to let its owner look away from the question. The symptom is doing something important. The older traditions said as much in another vocabulary: that affliction is not an accident that befalls the self but information about it.

This much, a growing number of mainstream dissenters from the serotonin story would grant. In the last decade those searching for depression’s true cause have waded upstream, finding multiple tributaries to explore. One school locates the disease in the mitochondria, the cell’s power plants, and reads it as a failure of brain energy metabolism^v. Another locates it in the reward system, and reads it as the debt the brain runs up when a flood of cheap, engineered pleasure forces it to turn down its own capacity to want^vi. A third locates it in chronic inflammation, or in the insulin resistance that increasingly travels beside it. Each is right exactly where the serotonin model was wrong: the cause is upstream, in the body, not in a single synapse. And each, having seen that much, repeats the original mistake at a different level of abstraction, crowning a new master mechanism and calling that the disease.

Mitochondria, dopamine, and inflammation are not three candidates competing for a single title. They are three instruments reading the same ground of being, and systems biology has learned to read them together: the links form a loop. Inflammation makes the body’s cells answer insulin poorly; the resulting overload damages the mitochondria; the damaged mitochondria spill reactive waste that inflames the tissues again. Those same mitochondria are the hub where the body under stress turns a dial, setting the amount of energy available for the brain’s reward circuits, the ones that decide whether an effort is worth making⁹. So a depleted terrain — starved of movement and sunlight and real food and sleep, saturated with the inputs it cannot metabolize — registers the loss in its energy metabolism, its reward circuitry, and its inflammatory load together, not because three machines happened to fail at once but because they were never three separate machines to begin with. To ask which is the cause is to ask whether the fever or the racing pulse is the truer sign of the infection. And the terrain claim makes a wager it can be judged by: restore the inputs, and the whole state should lift together rather than one mechanism at a time. That simultaneous lift has not yet been measured head-to-head; it is a prediction, not a result. But the terrain view does not need to refute the upstream findings. It is what they add up to.

This recasts the discipline problem too, because lack of discipline was never the fundamental problem. For an entire generation, willpower was imagined as a kind of fuel — a finite reserve that effort drains and rest restores. That model has not survived inspection: when twenty-three laboratories ran the decisive experiment in concert, the effect meant to prove it came in at essentially zero¹⁰, and the field now describes willpower not as a tank that empties but as attention following motivation. A readout, not a muscle. Dopamine, to run the risk of oversimplifying it as much as we have serotonin, plays a big role in providing motivation - the willingness to climb the hill and pay its cost. Unnaturally deplete it with cheap overstimulation and an animal takes the small reward it can have for nothing over the larger one that costs work — not because it doesn’t want the hard earned reward any longer, but because the engine that turns wanting into moving has run down¹¹.

Attention is the same faculty under another name: to hold the mind on one hard thing and to make oneself do one hard thing are a single capacity. The scattered mind and the slackened will are not two failures but one — and the flood of frictionless novelty that fractures focus is the same flood that drains the drive to act. This used to be common sense, and laboratory findings have been returning us to it: desire — the sense that something is worth its cost — comes first, and the will follows it the way a shadow follows a body walking towards the light. St. Augustine spoke of it sixteen centuries before there was a word for dopamine, likening love to a weight, a force that pulls the soul where it goes^vii. When desire is intact, discipline is nearly invisible; no one needs an accountability partner to do what they love, nor a focus app to attend to what they cannot look away from. When desire is gone, no system easily survives contact with the morning. Todos are downstream of the heart, and the heart is downstream of the terrain.

What the monks described in the language of demons, the physicians described in the language of the body. Melancholy, for Galen, was a disturbance of the whole constitution and not a single broken part; and the physician Ibn Sina, whose Canon taught European physicians for six centuries, carried that forward — melancholy belonged to the whole temperament, and could be met while still forming or left until it hardened, i.e. it was considered a condition whose treatment provided an easy window of opportunity that closes. It turns out this was no quaint intuition. In an individual-participant meta-analysis pooling ten cohorts and nearly 118,000 people, the constitutional cast a Galenic physician would have called melancholic — what moderns measure as neuroticism — both accompanied depression and was the less severe symptom that preceded it¹². Different ages arriving at the same place, one by way of assertion, often from higher first principles and the other by way of evidence: health is a property of the terrain, not of any single thing that happens to be standing on it, and the further that terrain deteriorates the harder it is to purge, replenish and rebuild it.

A healthy terrain is not a coddled one though. The body is neither built for constant comfort nor for constant alarm, but for intermittent stress: the brief, recoverable challenge that leaves it stronger. This is hormesis, and it is not folklore but a measured dose-response, in which a moderate, intermittent stressor — exertion, hunger, cold, the demand to solve something hard — triggers an adaptive overcompensation¹³. It is one reason why, in a head-to-head trial, physical exertion held its own against an antidepressant drug¹⁴: effort is a hormetic input the body expects and has usually been starved of by modern convenience.

But hormesis is only part of the equation. Another is what the terrain is built up from and what it is poisoned by, and there the lever is not stress but substance. When a randomized trial put depressed patients on whole food in place of the processed kind, roughly a third of them remitted against a twelfth of the controls, from nothing but the change of diet: inflammatory inputs withdrawn, the body’s raw materials restored¹⁵.Our tightly engineered environments get both halves wrong at once. They strip out the stressors the body is built to meet — movement, sunlight, hunger, cold, the friction of difficult work — and flood it with ones it cannot adapt to: stimulation calibrated to capture, light at midnight, food that inflames. A ground starved of what builds it and saturated with what wears it down will, eventually, send a sign, and the sign is the symptom.

If the lowest layers of a person can be inputs to the terrain, so can the highest. The very studies used to prove the efficacy of antidepressants depend in part on the placebo’s power - the difference between the sugar and the substance is nearly nil. When researchers look directly at what an inert pill does, they find real events in the brain: the release of the body’s own opioids and dopamine, measurable changes set off by nothing but the expectation of help and the meaning of the encounter¹⁶. The instrument designed to prove the drugs ends up proving an older claim instead: that meaning is a physiological force, not nice to have, but necessary. The same shows up at the scale of a life. In a study of nearly seven thousand adults, those with the least sense of purpose died at well over twice the rate of those with the most, across the full span of causes¹⁷. Viktor Frankl, who survived the camps and built an entire psychiatry based on what he saw there, made a line of Nietzsche’s the center of it: a person with a why to live can bear almost any how. The reasons a person lives for are not decoration laid over the biology. They are part of it.

All of this is why adding a simple remedy to an unchanged terrain so often fails. There is no simple solution when a hurricane hits. Repair and destruction cannot proceed at the same time; a body still being depleted cannot also be healing. The first move is not to add — not the supplement, not the stimulant, not a new system bolted onto an exhausted self — but to remove the inputs wearing you down. And the removing runs from the bottom up, the physical before the emotional before the things of meaning, because the higher faculties stand on the lower — Maslow knew that it’s very difficult to be reasoned or inspired into wanting what an exhausted body cannot yet supply. The mainstream’s most effective talking cure already obeys this logic without naming it: behavioral activation works by walking a person back toward the activities that once nourished them, which is a form of terrain restoration under another name. The desert monks with acedia had it for a very good reason: intense isolation, sensory deprivation, and the monotony of their ascetic routines. Their remedy was to stay — not to flee the cell or chase a new distraction, but to remove the impulse to escape, to remain with the work and tough it out until the noonday demon passed. We don’t have to do what they did. We can just get up and walk out of the room and back into a well-rounded life well-lived.

When the ground of being is restored and the true causes are addressed, something returns that no artificed system can manufacture: desire. The wanting comes back, and with it the effort, and with the effort the discipline and the focus that were never the problem to begin with. This is where real hope lies, and it is no small thing. The body is built to heal: it closes the open wound, knits the broken bone, and replaces the lining of the gut every few days without being told to, without needing a liniment or herb or pharmaceutical to do so. Restore the conditions it requires, and it will do the same with disease. The cure is neither automatic nor painless. It asks the one thing no system can supply: that the person actually change the life that emptied them, which means changing the self, which few are wont to do. Most will not, or cannot yet, and so the hope has to be framed honestly. Every disease has a cure; not every patient is willing to be cured. The noonday demon does not yield to a better todo list. It was never a territory to be mapped or ailment to be medicated but a message to be read, and it yields only when the one it afflicts stops trying to outrun it and begins, instead, to live in a way that gives the heart its reasons back.

---

You may have missed it in the byline, but we have a new staff writer, Gabriel Malachi, and this is his first of hopefully many pieces to come. Let us know what you think and what he should write about next.

While I’m here I can’t help but leave my two cents: prescriptions are always easier written and given than completed, and the easiest prescription to write is the general one. But that’s really the only kind that can be written for public consumption. Every article that lists a dozen things to do and not do to treat a particular disease is at best making something of a mockery of the human condition and at worst leading some to what may harm them though it helps another. Every good specific prescription is as specific as the person it’s written for. My wife asked me today what treatment would work for a disease and I said there are as many right treatments as there are people suffering with it. Perhaps a bit hyperbolic given the similarities people have with each other, we do tend to fall into groups after all, but it’s probably never more true than it is with depression, which can stem from so many causes and be treated with something as simple as a well-placed idea coming from someone who knows just how to say it to transform a long held worldview, or something as complicated as a multihour daily detox regimen. I’ve seen nothing seem to work for weeks or months and then suddenly the sun rises after someone starts taking just the right kind of propolis, or starts doing a tailored chi kung drill, or starts eating a few grams of roe. The operative word here is “seem”, while nothing may seem to be working, the groundwork is being laid for the change a person needs whether they’re making an effort to get better or not. The disease itself is often the cure for the problem you don’t even know you have, because the disease is just another creation, and the Creator cares more for us than we do for ourselves and knows just what we need to become our best selves.

-Dr Haider

Our thanks goes out to the long time reader who wrote in with the request that turned into this article: “write me something that will help me to adhere to goals, alleviate my depression and bring focus and discipline back into my life.” We hope this is that something for you.

References:

[i] Evagrius, *Praktikos*; carried to the Latin West by John Cassian, *Institutes*, Book X.

[ii] Cuijpers et al., network meta-analysis of psychotherapies for depression, *World Psychiatry*, 2021.

[1] Cipriani et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder. *Lancet* 2018;391(10128):1357–1366. PMID 29477251.

[2] Kirsch et al. Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the FDA. *PLoS Medicine* 2008;5(2):e45. PMID 18303940.

[3] Moncrieff et al. The serotonin theory of depression: a systematic umbrella review of the evidence. *Molecular Psychiatry* 2022. PMID 35854107.

[iii] Jauhar, Cowen, Browning et al., “A leaky umbrella has little value,” *Molecular Psychiatry*, 2023.

[iv] (Lacasse and Leo, *PLoS Medicine*, 2005).

[4] Turner et al. Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. *New England Journal of Medicine* 2008;358(3):252–260. PMID 18199864.

[5] Pigott et al. Efficacy and effectiveness of antidepressants: a reanalysis (STAR*D reanalysis). *BMJ Open* 2023;13(7):e063095. PMID 37491091.

[6] Dantzer et al. From inflammation to sickness and depression: when the immune system subjugates the brain. *Nature Reviews Neuroscience* 2008;9(1):46–56. PMID 18073775.

[7] Miller and Raison. The role of inflammation in depression: from evolutionary imperative to modern treatment target. *Nature Reviews Immunology* 2016;16(1):22–34. PMID 26711676.

[8] Andrews and Thomson. The bright side of being blue: depression as an adaptation for analyzing complex problems. *Psychological Review* 2009;116(3):620–654. PMID 19618990.

[v] Palmer, *Brain Energy*, 2022.

[vi] Lembke, *Dopamine Nation*, 2021.

[9] Picard and McEwen. Psychological Stress and Mitochondria: A Conceptual Framework. *Psychosomatic Medicine* 2018;80(2):126–140. PMID 29389735.

[10] Hagger et al. A Multilab Preregistered Replication of the Ego-Depletion Effect. *Perspectives on Psychological Science* 2016;11(4):546–573. PMID 27474142.

[11] Salamone and Correa. The Mysterious Motivational Functions of Mesolimbic Dopamine. *Neuron* 2012;76(3):470–485. PMID 23141060.

[vii] St Augustine’s Confessions, Book XIII.

[12] Hakulinen et al. Personality and Depressive Symptoms: Individual-Participant Meta-Analysis of 10 Cohort Studies. *Depression and Anxiety* 2015;32(7):461–470. PMID 26014798.

[13] Mattson. Hormesis defined. *Ageing Research Reviews* 2008;7(1):1–7. PMID 18162444.

[14] Blumenthal et al. Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder. *Psychosomatic Medicine* 2007;69(7):587–596. PMID 17846259.

[15] Jacka et al. A randomised controlled trial of dietary improvement for adults with major depression (the SMILES trial). *BMC Medicine* 2017;15(1):23. PMID 28137247.

[16] Wager and Atlas. The neuroscience of placebo effects: connecting context, learning and health. *Nature Reviews Neuroscience* 2015;16(7):403–418. PMID 26087681.

[17] Alimujiang et al. Association Between Life Purpose and Mortality Among US Adults Older Than 50 Years. *JAMA Network Open* 2019;2(5):e194270. PMID 31125099.